Albany, NY, United States of America

Michael J Spinella

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael J Spinella. Retrieved from https://idiyas.com/inventor/michael-j-spinella

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael J Spinella: Innovator in Endothelin Antagonists

Introduction

Michael J Spinella is a notable inventor based in Albany, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly through his work on endothelin antagonists. His innovative approach has led to the development of a unique compound that holds promise for various medical applications.

Latest Patents

Michael J Spinella holds one patent related to endothelin antagonists. This patent describes a compound that comprises an endothelin antagonist polypeptide, which is at least 40% homologous to an endothelin active peptide. The compound includes Et-1, Et-2, Et-3, SC, SA, and SB, and is formulated with pharmaceutically acceptable salts.

Career Highlights

Throughout his career, Spinella has focused on advancing medical science through innovative research. His work on endothelin antagonists showcases his commitment to developing new therapeutic options for patients. His contributions have been recognized within the scientific community, highlighting his role as a key inventor in this area.

Collaborations

Michael J Spinella has collaborated with Thomas T Andersen, working together to further their research and development efforts in the field of endothelin antagonists. Their partnership exemplifies the importance of collaboration in driving innovation and achieving breakthroughs in medical research.

Conclusion

Michael J Spinella's work on endothelin antagonists represents a significant advancement in pharmaceutical innovation. His dedication to research and collaboration with fellow inventors underscores the impact of his contributions to the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…